Development and Characterization of High-Absorption Microencapsulated Organic Propolis EPP-AF® Extract (i-CAPs)
Molecules · 17.10.2023 · 28 (20) · 7128
DOI: 10.3390/molecules28207128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 17.10.2023. Verfasst von Andresa A Berretta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Development & Innovation, Apis Flora Indl. Coml. Ltd.a., Ribeirão Preto 14020-670, Brazil. Hauptthemen laut MEDLINE: Propolis, Anti-Infective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, São Paulo Research Foundation, Fundação para a Ciência e Tecnologia.
Abstract (Originalsprache)
The demand for organic and functional food continues to increase yearly. Among the available functional foods, propolis is a bee product that has various beneficial properties, including antimicrobial, antioxidant, and anti-inflammatory activities. However, it generally is only available in ethanol solution, which has poor bioavailability, as it is relatively insoluble in water. The use of such ethanol extracts is often objectionable because of the alcohol content and because they have a strong and striking taste. Development of alternatives that can efficiently and safely increase solubility in water, and that meet organic production specifications, has been a challenge. To address these concerns, microcapsules were developed using spray-dryer technology from an emulsion based on EPP-AF® propolis and gum arabic (i-CAPS). These propolis-loaded microcapsules were characterized using FT-IR, SEM, TGA, HPLC, and spectrophotometric techniques, along with determination of antimicrobial, antioxidant, antitumor, anti-inflammatory, and antihypercholesterolemic activities, as well as permeability in in vitro models. The production system resulted in microcapsules with a spherical shape and an encapsulation efficiency of 93.7 ± 0.7%. They had IC50s of 2.654 ± 0.062 and 7.342 ± 0.058 µg/mL by FRAP and DPPH antioxidant methods, respectively. The EPP-AF® i-CAPS also had superior antimicrobial activity against Gram-positive bacteria. Antitumor activity was calculated based on the concentration that inhibited 50% of growth of AGS, Caco-2, and MCF-7 cell strains, giving results of 154.0 ± 1.0, 117 ± 1.0, and 271.0 ± 25 µg/mL, respectively. The microcapsule presentation reduced the permeation of cholesterol by 53.7%, demonstrating antihypercholesterolemic activity, and it improved the permeability of p-coumaric acid and artepillin C. The IC50 for NO production in RAW 264.7 cells was 59.0 ± 0.1 µg/mL. These findings demonstrate the potential of this new propolis product as a food and pharmaceutical ingredient, though additional studies are recommended to validate the safety of proposed dosages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research, Development & Innovation, Apis Flora Indl. Coml. Ltd.a., Ribeirão Preto 14020-670, Brazil.
- Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-903, Brazil.
- Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
- Laboratório Associado para a Sustentabilidade e Tecnologia em Regiões de Montanha (SusTEC), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
- Biopolymers and Biomaterials Group, University of Araraquara, UNIARA, Araraquara 14801-320, Brazil.
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo (FMRP/USP), Ribeirão Preto 14049-900, Brazil.
ORCID-Profile: Andresa A Berretta, Soraia I Falcão, Ricardo Calhelha, David De Jong, Miguel Vilas-Boas
Förderung
- National Council for Scientific and Technological Development
- São Paulo Research Foundation
- Fundação para a Ciência e Tecnologia
- Southern University of Science and Technology
- CNPq
- national funds FCT/MCTES
- SusTEC
- GreenHealth
Zitieren
APA
Berretta, A. A., De Lima, J. A., Falcão, S. I., Calhelha, R., Amorim, N. A., Gonçalves, I. S., Zamarrenho, L. G., Barud, H. D. S., Bastos, J. K., De Jong, D., & Vilas-Boas, M. (2023). Development and Characterization of High-Absorption Microencapsulated Organic Propolis EPP-AF® Extract (i-CAPs). Molecules, 28(20), 7128. https://doi.org/10.3390/molecules28207128
Vancouver
Berretta AA, De Lima JA, Falcão SI, Calhelha R, Amorim NA, Gonçalves IS, et al. Development and Characterization of High-Absorption Microencapsulated Organic Propolis EPP-AF® Extract (i-CAPs). Molecules. 2023;28(20):7128. doi:10.3390/molecules28207128
BibTeX
@article{Berretta2023,
author = {Berretta, Andresa A and De Lima, Jéssica A and Falcão, Soraia I and Calhelha, Ricardo and Amorim, Nathaly Alcazar and Gonçalves, Isabella Salgado and Zamarrenho, Luana Gonçalves and Barud, Hernane da Silva and Bastos, Jairo Kenupp and De Jong, David and Vilas-Boas, Miguel},
title = {Development and Characterization of High-Absorption Microencapsulated Organic Propolis EPP-AF® Extract (i-CAPs)},
journal = {Molecules},
year = {2023},
volume = {28},
number = {20},
pages = {7128},
doi = {10.3390/molecules28207128}
}
EUVIMED